Urology · Clinton, IA
NPI
1164476453
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
915 13th Ave N
Clinton, IA, 52732
Phone (563) 243-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,685 services
Medicare patients, 2024
479
Average age 77
Drug cost, 2024
$336K
3,045 prescriptions
Company payments, 2025
$35.06
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Margaret C Wolf was code 99213 (office e&m - established), 336 times for 265 patients. In total Margaret C Wolf billed 1,685 services in 54 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 336 | 265 | $43.07 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 328 | 245 | $10.97 | $3,597 |
| 99214 Office E&M - Established | Facility | 239 | 186 | $63.52 | $15K |
| 51702 Other Organ Systems | Facility | 177 | 19 | $17.09 | $3,024 |
| 99211 Office E&M - Established | Facility | 87 | 43 | $6.10 | $530 |
| 36415 Venipuncture Blood Collection | Office | 76 | 69 | $8.54 | $649 |
| 81001 Clinical Chemistry | Office | 74 | 70 | $3.08 | $228 |
| 52000 Cystourethroscopy | Facility | 55 | 44 | $51.97 | $2,858 |
| 99204 Office E&M - New | Facility | 50 | 50 | $92.11 | $4,606 |
| 74018 Standard X-ray | Facility | 42 | 30 | $5.91 | $248 |
| 99203 Office E&M - New | Facility | 28 | 28 | $47.50 | $1,330 |
| 52356 Calculus Removal - Urinary | Facility | 12 | 12 | $293.94 | $3,527 |
By year: 2022 $93K for 2,112 services; 2023 $79K for 1,680 services; 2024 $67K for 1,685 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 76 | 69 | $8.54 | $649 |
| 81001 Clinical Chemistry | 74 | 70 | $3.08 | $228 |
Medicare prescription drug claims, 2024
In 2024, the drug Margaret C Wolf prescribed most often to Medicare patients was Cephalexin, with 863 prescriptions and refills. In total Margaret C Wolf wrote 3,045 Medicare prescriptions that cost $336K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 863 | 1,452 | 200 | $6,941 |
| Myrbetriq Mirabegron | 335 | 450 | 66 | $201K |
| Finasteride Generic | 305 | 583 | 65 | $2,316 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 282 | 450 | 67 | $4,165 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 252 | 372 | 84 | $1,748 |
| Tamsulosin Hcl Generic | 240 | 507 | 67 | $2,053 |
| Solifenacin Succinate Generic | 116 | 196 | 30 | $3,745 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 111 | 184 | 40 | $3,505 |
| Levofloxacin Generic | 84 | 84 | 68 | $195 |
| Elmiron Pentosan Polysulfate Sodium | 67 | 83 | Under 11 | $71K |
| Amoxicillin Generic | 52 | 108 | 18 | $232 |
| Gemtesa Vibegron | 38 | 48 | Under 11 | $23K |
| Trimethoprim Generic | 36 | 58 | 13 | $2,307 |
| Oxybutynin Chloride Generic | 33 | 63 | Under 11 | $954 |
| Allopurinol Generic | 31 | 60 | Under 11 | $150 |
Brand drugs: 479 claims; generic drugs: 2,566 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Margaret C Wolf $35.06 ($35.06 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $35.06.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $35.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.